LENZ Therapeutics, Inc. - LENZ

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Mar 30, 2026 President, CEO and Secretary P A 28,089.0 8.9505 251,410.59 77,289.0 View
Mar 30, 2026 P A 5,592.0 8.9217 49,890.15 5,592.0 View
Mar 30, 2026 Chief Financial Officer P A 7,500.0 8.57 64,275.0 12,886.0 View
Jan 06, 2026 Chief Financial Officer A A 14,000.0 0.0 0.0 14,000.0 View
Jan 06, 2026 Chief Financial Officer A A 84,200.0 0.0 0.0 84,200.0 View
Jan 06, 2026 President, CEO and Secretary A A 358,100.0 0.0 0.0 358,100.0 View
Jan 06, 2026 Chief Medical Officer A A 14,000.0 0.0 0.0 14,000.0 View
Jan 06, 2026 Chief Medical Officer A A 84,200.0 0.0 0.0 84,200.0 View
Jan 06, 2026 Chief Commercial Officer A A 14,000.0 0.0 0.0 14,000.0 View
Jan 06, 2026 Chief Commercial Officer A A 84,200.0 0.0 0.0 84,200.0 View
Nov 19, 2025 Chief Commercial Officer M D 10,000.0 0.0 0.0 53,241.0 View
Nov 19, 2025 Chief Commercial Officer S D 5,788.0 26.3669 152,611.62 4,733.0 View
Nov 19, 2025 Chief Commercial Officer S D 4,212.0 25.7385 108,410.56 10,521.0 View
Nov 19, 2025 Chief Commercial Officer M A 10,000.0 2.08 20,800.0 14,733.0 View
Nov 10, 2025 P A 10,500.0 22.7884 239,278.2 10,500.0 View
Nov 07, 2025 Chief Financial Officer P A 2,178.0 22.7561 49,562.79 5,386.0 View
Nov 07, 2025 Chief Financial Officer P A 20.0 22.71 454.2 3,208.0 View